To print this list, use your browser's print command. This page has no form, and it does not save what you read.
-
Is my knee pain coming from arthritis, or could something else be causing it?
Knee pain does not always come from arthritis in the joint. Ask what your exam and images show, and whether anything else could explain your pain.
-
What do my X-rays show, and how severe is my arthritis?
GAE studies have included mild to severe arthritis on X-rays, but pain tended to improve more in mild to moderate arthritis than in severe arthritis2.
-
Do I need an MRI or other scans before GAE?
Before GAE, teams usually look at a recent standing knee X-ray and a recent knee MRI2. Ask what the scans are checking for.
-
Have I tried enough of the usual first treatments?
An arthritis guideline strongly recommends exercise, weight loss for people who are overweight, and self-management programs, among other first steps3. GAE has mostly been studied in people whose pain lasted despite 3 to 6 months of other treatment2.
-
Does my situation match the people GAE has been studied in?
Most studies included adults over 40 whose pain lasted despite other treatment2. SIR describes GAE for people whose pain has not improved with other care and who cannot have, do not want, or want to put off a knee replacement4.
-
Is there anything about my health that makes GAE riskier for me?
Ask about kidney problems, allergies to X-ray dye, blood thinners, and problems with the arteries in your legs or arms.
-
How much might my pain improve, and when?
If relief comes, it may start within hours to weeks2. In one early single-center, uncontrolled study, about 80% of patients still had meaningful relief 3 years after GAE5. Ask how you and your doctor will measure the change.
-
How does GAE compare with a sham procedure in trials?
Sham-controlled trials are mixed. One small trial found less pain after GAE at 1 month, and two larger trials found no clear difference6,7,8. Read what studies show so far.
-
Which particles will you use, and why?
Some doctors use particles that dissolve over time, and others use permanent ones. Skin color change is seen more often with permanent particles, and there is no agreed best choice yet4.
-
What side effects are common?
In one review, skin color change over the knee happened in about 16 in 100 people, and short-term knee pain in about 10 in 1009. Skin changes usually fade within a month4. Read about GAE side effects and recovery.
-
What is non-target embolization, and how do you lower the risk?
It means particles reach a small artery that was not meant to be treated, most often one that feeds the skin over the knee2. Rarely, it causes a skin sore, in about 3 in 1,000 people4. Ask how the team checks the arteries before placing particles.
-
If GAE does not help, what comes next, and could I still have a knee replacement?
GAE does not rule out surgery later2. In one study, 9 of 46 people later had a knee replacement, and their surgeons reported no added difficulty10. A repeat GAE may be considered after about 12 months2.
-
Will my insurance or Medicare cover GAE?
Medicare has no coverage policy written specifically for GAE, so ask your doctor's office and your plan before you schedule11. Some commercial insurers call GAE investigational12,13. Ask which codes will be billed. Read about GAE insurance and Medicare coverage.
-
How many GAE procedures have you done, and how do you track results?
NICE, which reviews treatments in the UK, says GAE should only be done by interventional radiologists with specific training in it14. Ask about your doctor's experience and how they follow up with patients.
-
Who will coordinate my care with my orthopedic surgeon and primary care doctor?
Ask how the interventional radiologist will share results with your other doctors, and who to call with questions after GAE.
Talk with your doctor before you decide. This information does not replace personal medical advice. Read the medical disclaimer.
Sources
- Collettini et al., embolization for knee osteoarthritis: mechanism and current results, Deutsches Ärzteblatt International 2026 (PMID 41495011) ↩︎
- Brown et al., genicular artery embolization: a technical review, Journal of Clinical Medicine 2025 (PMID 40142914) ↩︎
- Kolasinski et al., 2019 American College of Rheumatology/Arthritis Foundation osteoarthritis guideline, Arthritis Care & Research 2020 (PMID 31908149) ↩︎
- Ahmed et al., Society of Interventional Radiology position statement on genicular artery embolization, Journal of Vascular and Interventional Radiology 2026 (PMID 42118083) ↩︎
- Okuno et al., midterm results after embolization for knee osteoarthritis, Journal of Vascular and Interventional Radiology 2017 (PMID 28365171) ↩︎
- Bagla et al., multicenter sham-controlled trial of GAE, Journal of Vascular and Interventional Radiology 2022 (PMID 34610422) ↩︎
- Landers et al., triple-blind sham-controlled trial of GAE, Bone & Joint Open 2023 (PMID 37051829) ↩︎
- van Zadelhoff et al., double-blind sham-controlled trial of GAE, 4-month results, BMJ Open 2024 (PMID 39353688) ↩︎
- Ashraf et al., systematic review of GAE safety and results, 2025 (PMID 40219609) ↩︎
- Little et al., GENESIS long-term results, CardioVascular and Interventional Radiology 2024 (PMID 38819473) ↩︎
- CMS, Medicare Coverage Database (searched October 2026) ↩︎
- Blue Cross and Blue Shield of Texas, medical policy SUR705.048, effective July 15, 2025 ↩︎
- Molina Clinical Policy No. 410, genicular artery embolization of the knee for osteoarthritis ↩︎
- NICE (UK), genicular artery embolisation for pain from knee osteoarthritis, HTG595 (formerly IPG708), 2021 ↩︎